Cardiovascular Diseases Research in Vermont
Cardiovascular Diseases Research (93.837) awarded $36.6 million to recipients in Vermont in 34 grants from fiscal 2021 to 2025, 0.3% of the program's national total. University of Vermont & State Agricultural College received the most, $34.6 million.
- Awarded in Vermont$36.6 million
- Awards34
- Share of the program0.3%
- Rank among states35th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 20 | $10.6 million |
| FY 2022 | 17 | $9.3 million |
| FY 2023 | 13 | $6.8 million |
| FY 2024 | 12 | $5.2 million |
| FY 2025 | 12 | $4.7 million |
Recipients in Vermont
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Vermont & State Agricultural College | Colleges and universities | 32 | $34.6 million |
| CPR Therapeutics Inc. | Small businesses | 1 | $1.7 million |
| Samba Biologics Inc. | Small businesses | 1 | $498,271 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Vermont?
$36.6 million from fiscal 2021 to 2025, across 34 awards. Vermont ranks 35th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Vermont?
The largest recipient is University of Vermont & State Agricultural College, with $34.6 million in 32 awards. Next are CPR Therapeutics Inc. and Samba Biologics Inc..
Can organizations in Vermont apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Vermont
- Grants to States for Medicaid
- Highway Planning and Construction
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Education Stabilization Fund
- Temporary Assistance for Needy Families
- Broadband Equity, Access, and Deployment Program
- National School Lunch Program
- Drinking Water State Revolving Fund
- Title I Grants to Local Educational Agencies
- Special Education Grants to States